Brad Karp

In addition to his role as chairman of Paul, Weiss, Rifkind, Wharton & Garrison LLP, New York-based Brad Karp remains a sought-after trial lawyer, notably representing Regeneron Pharmaceuticals in a False Claims Act and Anti-Kickback Statute suit brought by the DOJ, alleging it paid kickbacks to a co-pay foundation with the intention of increasing sales of its macular degeneration drug Eylea and thereby increase reimbursement rates from Medicare.